Immediate Impact
2 from Science/Nature 60 standout
Citing Papers
The therapeutic potential of circular RNAs
2025 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
Works of Ken Ohmachi being referenced
A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma
2019
Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ken Ohmachi | 397 | 335 | 204 | 46 | 581 | |
| Parth Desai | 287 | 281 | 181 | 50 | 545 | |
| Emmanuelle Nicolas‐Virelizier | 407 | 273 | 184 | 57 | 561 | |
| Roberto Freilone | 414 | 314 | 224 | 44 | 575 | |
| Santiago Mercadal | 545 | 390 | 226 | 55 | 681 | |
| Flora N. Kontopidou | 422 | 213 | 251 | 36 | 607 | |
| Naohiro Sekiguchi | 390 | 250 | 202 | 60 | 550 | |
| Matteo Dell’Olio | 366 | 266 | 279 | 29 | 606 | |
| Giulia Cervetti | 336 | 248 | 255 | 37 | 601 | |
| Fiona Miall | 555 | 423 | 289 | 32 | 725 | |
| Judith Huerta‐Guzmán | 396 | 396 | 94 | 42 | 655 |
All Works
Loading papers...